Reimbursed treatments are steadily displacing discounted programs.
Neuraxis, Inc. (NRXS) News
Latest headlines that mention NRXS, newest first · each headline opens the original publisher
- Last price
- $4.50
- Day change
- -7.60%
- Next earnings
- —
NRXS headlines
latest coverageNot much coverage yet. NRXS has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Revenue surged 116% as insurance coverage expanded and device pricing climbed.
NRXS news alerts
Get an alert by email or push when a new headline mentions NRXS.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.